Introduction {#s1}
============

Follicular helper CD4 T cells (T~FH~) are crucial for the development of antigen-specific B cells within germinal centers (GC). T~FH~ cells interact through co-stimulatory receptors and provide essential soluble factors (i.e. IL-4, IL-21) to promote the survival, isotype switching and selection of high affinity memory B cells [@ppat.1003853-Crotty1]. Phenotypic and gene signature analysis has revealed a highly conserved molecular profile of T~FH~ cells in humans, non-human primates (NHP) and mice, which is characterized by increased expression of Bcl-6, CXCR5, PD-1, ICOS and decreased expression of CCR7 [@ppat.1003853-Haynes1]--[@ppat.1003853-Petrovas1]. Human T~FH~ cells exhibit a polarized cytokine profile characterized by compromised production of T~H1~ cytokines and increased secretion of IL-4, IL-10 and IL-21 [@ppat.1003853-Kim1]. Although IL-21 is characterized as a "hallmark" cytokine of T~FH~ cells, other T~Helper~ subsets produce this cytokine [@ppat.1003853-Yu1].

The origin and differentiation of T~FH~ is unclear, as previous studies found T~FH~ cells can derive from T~H1~ or T~H2~ cells, or independently of other CD4 lineages [@ppat.1003853-Fahey1]--[@ppat.1003853-Nurieva1]. However, it is well established that the transcription factor Bcl-6 regulates several molecules involved in T~FH~ development (i.e. PD-1, IL-21R, CXCR5) [@ppat.1003853-Nurieva2], [@ppat.1003853-Yu2]. Similarly, the fate of T~FH~, particularly those in the germinal center (GC-T~FH~), following the effector phase of the immune response is unclear. We have recently shown that NHP GC-T~FH~ display compromised *in vivo* cell cycling and are prone to *in vitro* cell death [@ppat.1003853-Petrovas1]. Other studies have shown that T~FH~ can form a memory pool found in anatomical sites outside the lymph nodes [@ppat.1003853-Luthje1]. Hence, T~FH~ cells may adopt a "central memory" phenotype or undergo cell death after the effector phase [@ppat.1003853-Pepper1]. In humans, a circulating CD4 T cell population characterized by high CXCR5 expression can provide *in vitro* help for B cell isotype switching and shares functional characteristics with T~FH~ cells [@ppat.1003853-Morita1]. It was proposed that these circulating cells, termed "peripheral T~FH~" (pT~FH~) could represent the memory counterparts of T~FH~ outside the lymphoid organs. Further investigation is needed to establish a direct relationship between T~FH~ cells and pT~FH~ cells.

It is becoming increasingly important to understand the interplay between CD4 T cells and B cells during HIV infection, specifically with relation to the generation of broadly neutralizing antibodies. Chronic HIV/SIV infection results in profound changes in CD4 T cell dynamics in lymph nodes characterized by T~FH~ accumulation and increased ability of non-T~FH~ to egress the lymph node [@ppat.1003853-Petrovas1], [@ppat.1003853-Lindqvist1]. How this impacts upon the dynamics of pT~FH~ is unknown. Elucidating the biology and dynamics of pT~FH~, and their ability to provide B cell help may be important for our understanding of T~FH~ memory formation during chronic infection, as well as the establishment of immune correlates reflecting the interactions between CD4 T cells and B cells within secondary lymphoid organs. This is of particular interest for monitoring clinical studies where the B cell arm of the immune system is under investigation [@ppat.1003853-Pallikkuth1].

Here we define, detect, quantify and characterize peripheral CD4 T cell populations that support B cell differentiation. We show that particular circulating CD4 T cell populations with distinct cytokine profiles have the capacity to help B cells *in vitro*. We further show that the frequencies of pT~FH~ populations are significantly compromised during chronic HIV infection but can recover with antiretroviral treatment (ART), although *in vitro* immunoglobulin production from HIV-infected subjects both on and off ART is reduced compared to healthy subjects. Furthermore, gene expression analysis of pT~FH~ cells and CD4 T cells in tonsil tissue suggest pT~FH~ cells are most closely related to a non-T~FH~ memory population within secondary lymphoid organs. Overall, our data challenge the relationship between pT~FH~ cells and T~FH~ memory cells.

Results {#s2}
=======

Characterization of peripheral T follicular helper (pT~FH~) cells {#s2a}
-----------------------------------------------------------------

Previous studies defined a population of circulating CD4 T cells that express CXCR5, promote the differentiation of naïve B cells and induce immunoglobulin secretion *in vitro* [@ppat.1003853-Morita1], [@ppat.1003853-Chevalier1]. We further defined CXCR5^high^ CD4 T cells from blood, analyzed their cytokine production and determined their ability to promote B cell differentiation *in vitro*. CXCR5^high^ CD4 T cells were found predominantly within the CD27^high^CD45RO^high^ CD4 T cell population (hereafter referred to as central memory (CM)), in agreement with previous studies [@ppat.1003853-Chevalier1]. The majority of the CXCR5^high^ CD4 T cell population also expressed CCR7 and we found the CCR7^high^CXCR5^high^ population represented 6.5+/−2.8% (mean+/−S.D.) of total CD4 T cells in healthy subjects ([Figure 1A](#ppat-1003853-g001){ref-type="fig"}). The majority of CXCR5^high^ cells expressed CD150. We further analyzed these cells based on expression of CCR6, which was previously used in combination with CXCR3 to define a pT~FH~ subset that promotes IgG and IgA production [@ppat.1003853-Morita1], and PD-1. CCR7^high^CXCR5^high^CCR6^high^ cells represented 1.2+/−0.9% of total CD4 T cells and a minority of these cells were PD-1^high^.

![Characterization of peripheral T~FH~ cells.\
(**A**) Left: Representative flow cytometry plots from HIV-uninfected PBMC showing the gating scheme for isolating T cell subsets for the T cell/B cell coculture assay. Isolated populations include naïve cells (brown), CM CCR7^low^ (pink), CM CCR7^high^CXCR5^low^ (orange), CM CCR7^high^CXCR5^high^CCR6^low^PD-1^high^ (green), CM CCR7^high^CXCR5^high^CCR6^high^PD-1^low^ (blue) and CCR7^high^CXCR5^high^CCR6^high^PD-1^high^ (red). Before gating on CCR6 and PD-1, cells were first gated on CD150^high^. Right: Scatter plot indicating the frequency of each population in HIV-uninfected subjects (*n* = 13). Cells were not gated on CD150 for phenotypic analysis. (**B**) Indicated CD4 T cell populations were cultured with autologous naïve B cells (CD19^high^CD27^low^IgD^−^) in the presence of SEB for 12 days and Ig concentrations were measured from supernatants (n = 6). (**C**) Indicated CD4 T cell populations were cultured with autologous naïve B cells in the presence of SEB for 2 days and cytokine concentrations were measured from supernatants (n = 6). Horizontal lines indicate limit of detection. Significant differences were determined using the Friedman test with Dunn\'s multiple comparison post-test. \*p\<0.05; \*\*p\<0.01.](ppat.1003853.g001){#ppat-1003853-g001}

To analyze the ability of these populations to promote B cell differentiation, naïve and CM CD4 T cells from HIV-uninfected individuals were sorted based on expression of CCR7, CXCR5, CD150, CCR6 and PD-1 ([Figure 1A](#ppat-1003853-g001){ref-type="fig"}), and cultured with autologous naïve B cells (CD19^+^CD27^−^IgD^+^) as previously described [@ppat.1003853-Morita1], [@ppat.1003853-Breitfeld1] in the presence of staphylococcal enterotoxin B (SEB). Notably, our sorted naïve B cell population did not express isotype-switched immunoglobulin ([Figure S1A](#ppat.1003853.s001){ref-type="supplementary-material"}) and culture conditions that lacked SEB did not induce immunoglobulin production (data not shown). Naïve and CM CCR7^low^ CD4 T cells failed to promote B cell differentiation and immunoglobulin production whereas CM CCR7^high^CXCR5^low^ cells induced limited production of IgM, IgG1 and IgG3 compared to the CCR7^high^CXCR5^high^ populations ([Figure 1B](#ppat-1003853-g001){ref-type="fig"}). The CCR7^high^CXCR5^high^CCR6^high^PD-1^high^ population induced the greatest production of IgG1, IgG3 and IgA compared to the CXCR5^low^ population. Prior studies defined pT~FH~ cells based on surface expression of CXCR5, CCR6 and the lack of CXCR3 expression [@ppat.1003853-Morita1]. We found that the greatest help for immunoglobulin production was from CXCR5^high^CCR6^high^ cell populations and, within those, from the PD-1^high^ cells. We did not eliminate a small population of CXCR3^+^ cells in order to avoid removing a larger population of CXCR5^high^CCR6^high^ cells that induce B cell differentiation ([Figure S1B](#ppat.1003853.s001){ref-type="supplementary-material"}).

The cytokine profile of pT~FH~ populations shared characteristics with other T~helper~ subsets, including T~H1~, T~H17~ and T~reg~ cells. Supernatant from the CXCR5^high^CCR6^high^PD-1^low^ coculture contained the greatest quantities of TNF-α, IL-2, and IL-17 compared to the CXCR5^high^CCR6^low^PD-1^high^ coculture ([Figure 1C](#ppat-1003853-g001){ref-type="fig"}). Notably, the CXCR5^high^CCR6^high^PD-1^high^ population, which promoted the greatest production of IgG1, IgG3 and IgA, showed the greatest IL-21 production, although at low levels.

Overall, CXCR5^high^ CD4 T cell populations induced B cell immunoglobulin production, although the CXCR5^high^CCR6^high^PD-1^high^ population did so most efficiently. However, this population is not characteristic of a T~FH~ population found in secondary lymphoid organs, as coculture supernatants included a broad array of cytokines characteristic of T~FH~ cells and multiple other T~helper~ subsets.

Progressive loss of pT~FH~ cells in HIV infection {#s2b}
-------------------------------------------------

To determine the impact of HIV on pT~FH~ populations, we compared pT~FH~ cells from HIV-uninfected subjects and treatment-naïve HIV-infected subjects ([Table S1](#ppat.1003853.s004){ref-type="supplementary-material"}) as a frequency of total CD4 cells. Irrespective of how pT~FH~ cells were defined, there was a significant decrease in the pT~FH~ population from HIV-infected subjects compared to HIV-uninfected subjects ([Figure 2A](#ppat-1003853-g002){ref-type="fig"}). Subjects with CD4 counts greater than 200 had significantly lower pT~FH~ populations, while subjects with CD4 counts less than 200 had the lowest frequency of all phenotypically defined pT~FH~ populations. However, when we defined the CCR6^high^PD-1^high^ population as a subset of the CXCR5^high^ population, the frequency of the CCR6^high^PD-1^high^ population increased in subjects with CD4 counts less than 200 ([Figure S2A](#ppat.1003853.s002){ref-type="supplementary-material"}). The increase in PD-1^high^ cells was likely due to immune activation in HIV infection, as we observed increases in the frequency of both PD-1^high^ and ICOS^high^ cells within the CXCR5^high^ population, with the greatest increases seen in samples with CD4 counts less than 200 ([Figure S2A](#ppat.1003853.s002){ref-type="supplementary-material"}). We also observed a positive trend between CXCR5^high^PD-1^high^ cells and serum concentrations of soluble CD14. ([Figure S2A](#ppat.1003853.s002){ref-type="supplementary-material"}). For 10 HIV-infected individuals on whom we had longitudinal samples, we observed a loss of pT~FH~ populations as a frequency of total CD4 T cells over 36 to 48 months ([Figure 2B](#ppat-1003853-g002){ref-type="fig"}). However, the frequency of PD-1^high^, ICOS^high^ and CCR6^high^PD-1^high^ cells within the CXCR5^high^ population remained stable ([Figure S2B](#ppat.1003853.s002){ref-type="supplementary-material"}).

![Progressive loss of pT~FH~ cells in HIV infection.\
(**A**) Pooled data showing the frequency (%) of CXCR5^high^, CXCR5^high^CCR6^high^ and CXCR5^high^CCR6^high^PD-1^high^ populations in total CD4 cells from PBMC from HIV uninfected (open circles; n = 13), HIV-infected (treatment-naïve), CD4 count \>200 (light gray circles; n = 44), and HIV-infected (treatment-naïve), CD4 count \<200 (black circles; n = 22). Significant differences between HIV-uninfected and HIV-infected subjects were determined using the Mann-Whitney U test. \*\*\*p\<0.001; \*\*p\<0.01; \*p\<0.05. (**B**) Longitudinal analysis showing the frequency (%) of CXCR5^high^, CXCR5^high^CCR6^high^ and CXCR5^high^CCR6^high^PD-1^high^ populations in total CD4 cells or indicated populations in CXCR5-expressing cells (bottom row) from HIV-infected (treatment naïve) subjects (n = 10) over 36--48 months. No significant correlations were found. (**C**) Pooled data showing the frequency (%) of CXCR5^high^, CXCR5^high^CCR6^high^ and CXCR5^high^CCR6^high^PD-1^high^ populations in total CD4 cells from PBMC from HIV-uninfected subjects (open circles; n = 13) and HIV-infected subjects before (n = 14, week 0; black circles) and after ART (week 24, dark gray circles; week 48, light gray circles). Significant differences between HIV-uninfected and HIV-infected subjects were determined using the Mann-Whitney U test. Significant differences between subjects before and after ART were determined using the Wilcoxon matched-pairs signed rank test. \*\*\*p\<0.001; \*\*p\<0.01; \*p\<0.05.](ppat.1003853.g002){#ppat-1003853-g002}

Next, we investigated the impact of ART on the frequency of pT~FH~ within total CD4 T cells. Longitudinal analysis on samples from before and after 24 and 48 weeks of ART revealed a recovery of pT~FH~ populations ([Figure 2C](#ppat-1003853-g002){ref-type="fig"}). However, the frequency of PD-1^high^, ICOS^high^ and CCR6^high^PD-1^high^ cells remained stable within the CXCR5^high^ population ([Figure S2C](#ppat.1003853.s002){ref-type="supplementary-material"}). Overall, HIV infection causes a loss of pT~FH~ cells and ART promotes the recovery of these populations.

Impaired B cell help by pT~FH~ cells in HIV infection {#s2c}
-----------------------------------------------------

To investigate the impact of HIV on the ability of pT~FH~ cells to support B cell differentiation, we performed co-culture experiments with pT~FH~ cells from HIV-infected subjects. We focused on the CXCR5^high^CCR6^high^ population that included both PD-1^high^ and PD-1^low^ cells due to limited cell numbers in HIV-infected subjects. Similar to previous results, the CXCR5^high^CCR6^high^ population from HIV-uninfected subjects supported significantly more immunoglobulin production compared to the CXCR5^low^ population. ([Figure 3A](#ppat-1003853-g003){ref-type="fig"}). However, for HIV-infected subjects we observed less overall immunoglobulin production when CXCR5^high^CCR6^high^ CD4 T cells were co-cultivated with naïve B cells. Furthermore, in viremic subjects, we observed increased IgM and IgG1 production in co-culture supernatants from the CXCR5^low^ population, compared to HIV-uninfected subjects. Similar to HIV-uninfected subjects, we found that pT~FH~ cells from HIV-infected subjects produced a broad spectrum of cytokines ([Figure S3A](#ppat.1003853.s003){ref-type="supplementary-material"}).

![Impaired B cell help by pT~FH~ cells in HIV infection.\
(**A**) CCR7^high^CXCR5^low^ and CCR7^high^CXCR5^high^CCR6^high^ CM CD4 T cells isolated from PBMCs were cultured with autologous naïve B cells (CD19^high^CD27^low^IgD^−^) in the presence of SEB for 12 days and Ig concentrations were measured from supernatants (HIV-uninfected, n = 8; HIV-infected (non-viremic), n = 5--7, HIV-infected (viremic), n = 1--2). Significant differences were determined using the Wilcoxon paired t-test or the Mann-Whitney test. \*p\<0.05; \*\*p\<0.01. (**B**) Top: HIV-uninfected PBMCs were incubated with indicated concentrations of CXCL-13 for 1 hour at 37°C (red) or 4°C (black). Bottom: Healthy PBMCs were incubated with 1 µg/mL CXCL13 for 10, 30, 60 or 120 minutes at 37°C (red) or 4°C (black). The frequency of CXCR5-positve CD4 T cells was calculated and normalized to time 0. (n = 3). (**C**) Top: Correlative analysis showing the frequency of CM CXCR5-positive CD4 T cells versus viral load (n = 27; r = −0.4036, P = 0.0368). Bottom: Correlative analysis showing the concentration of CXCL-13 in plasma or sera versus viral load (n = 27; r = 0.4414, P = 0.0165). Correlations were analyzed using the nonparametric Spearman test.](ppat.1003853.g003){#ppat-1003853-g003}

Our data raise the possibility that some pT~FH~ cells exhibit a CXCR5^low^ phenotype in HIV infection. This phenotype could be due the down regulation of CXCR5 on pT~FH~ cells, or indicate the existence of a unique CXCR5^low^ pT~FH~ population in chronic HIV infection. In order to distinguish these two possibilities, we investigated whether CXCL-13 impacts CXCR5 expression on CD4 T cells. We found that incubation of HIV-uninfected PBMC with CXCL-13 led to a decrease in frequency of CXCR5-positive CD4 T cells, presumably due to the internalization of CXCR5 ([Figure 3B](#ppat-1003853-g003){ref-type="fig"}). Furthermore, in HIV infection we found that viral load positively correlated with CXCL-13 levels and negatively correlated with the frequency of CXCR5-positive CD4 T cells ([Figure 3C](#ppat-1003853-g003){ref-type="fig"}). However, we did not observe a direct correlation between CXCL13 levels and the frequency of CXCR5-positive CD4 T cells. Importantly, we also found that *in vitro* infection of CXCR5-expressing CD4 T cells did not impact CXCR5 surface expression ([Figure S3B](#ppat.1003853.s003){ref-type="supplementary-material"}). Therefore, our data support the possibility that in untreated HIV infected individuals, increased levels of CXCL-13 could effect CXCR5 surface expression on pT~FH~ cells.

Defective cytokine production of pT~FH~ in HIV infection {#s2d}
--------------------------------------------------------

T~FH~-dependent B cell differentiation requires IL-21. To characterize directly cytokine production from pT~FH~ cells from HIV-uninfected and HIV-infected subjects, we performed intracellular cytokine staining after *ex vivo* SEB stimulation. In addition to surface markers used to define pT~FH~ cells, we detected CD154, IFN-γ, IL-2, IL-17 and IL-21 ([Figure 4A](#ppat-1003853-g004){ref-type="fig"}). In HIV-uninfected individuals, a minority of CD154-positive, cytokine-positive cells express a CCR7^high^ phenotype (10.1% of IFN-γ positive cells; 28% of IL-2-positive cells; 19.4% of IL-17-positive cells and 17.9% of IL-21-positive cells), while a gradual reduction of cytokine production was found in further differentiated cells based on CXCR5 and CCR6 expression ([Figure 4B](#ppat-1003853-g004){ref-type="fig"}). However, for all of the cytokines detected, we observed a population of cells that were CCR7^high^CXCR5^high^CCR6^high^, including IL-21-producing cells. Overall, we determined that a mean of 4.5% of CD154-positive IL-21-positive cells were CCR7^high^CXCR5^high^CCR6^high^ ([Figure 4B](#ppat-1003853-g004){ref-type="fig"}). However, this pT~FH~ population also produced IFN-γ, IL-2 and IL-17 (0.8% of IFN-γ positive cells; 9.0% of IL-2-positive cells and 7.1% of IL-17-positive cells).

![Functional characteristics of pT~FH~ cells and the impact of HIV.\
(**A**) Representative flow cytometry plots showing CM, CD154-positive, cytokine-positive cells after SEB stimulation. CD154-positive, cytokine-positive CD4 T cells, shown by contour plots (blue: HIV-uninfected; red: HIV-infected), are overlaid onto 2 dimensional density plots for CM CD4 T cells plotted against CCR7 and CD3, and CXCR5 and CCR6. (**B**) Bar graphs showing the frequency of SEB-stimulated CD154-positive, cytokine-positive cells that express CCR7, CXCR5 and CCR6 (Blue: uninfected; n = 5; Red: HIV-infected; n = 24). (**C**) Left: Gag-specific CD4+ T cells (CD154-positive, cytokine-positive) shown as red contour plots are overlaid onto 2 dimensional density plots for CM cells CD4 T cells plotted against CCR7 and CD3, and CXCR5 and CCR6. Right: Bar graphs showing the frequency of Gag-specific CD154-positive, cytokine-positive cells that express CCR7, CXCR5 and CCR6 (n = 14). \*p\<0.05.](ppat.1003853.g004){#ppat-1003853-g004}

Next, we analyzed cytokine production from HIV-infected subjects off-treatment. Overall, we observed a loss of cytokine-producing cells from the CCR7^high^ population and a general shift towards the CXCR5^low^CCR6^low^ population ([Figure 4A](#ppat-1003853-g004){ref-type="fig"}). Thus, we observed a loss of CCR7^high^CXCR5^high^CCR6^high^ pT~FH~ cells that produce IL-2, IL-17 and IL-21 ([Figure 3B](#ppat-1003853-g003){ref-type="fig"}; IL-2: 9.0% for HIV-negative vs 2.0% for HIV-positive; IL-17: 7.1% for HIV-negative vs 2.2% for HIV-positive; IL-21: 4.5% for HIV-negative vs 1.1% for HIV-positive).

To analyze HIV-specific cells, PBMC were stimulated with Gag peptide pools and analyzed for cytokine expression. Very few IL-2-positive and IL-17-positive cells were detected within the CM compartment (data not shown). Gag-specific IFN-γ and IL-21-producing cells were detected, however, compared to SEB-stimulation fewer HIV-specific cells expressed CCR7 (4.4% vs 10.7% of IFN-γ positive cells; 3.5% vs 11.9% of IL-21-positive cells for Gag and SEB stimulation, respectively). A majority of HIV-specific cells were not CCR7^high^CXCR5^high^CCR6^high^ ([Figure 4C](#ppat-1003853-g004){ref-type="fig"}; 0.4% of IFN-γ positive cells and 0.9% of IL-21-positive cells were CCR7^high^CXCR5^high^CCR6^high^).

Overall, we observed IL-21 production from the CCR7^high^CXCR5^high^CCR6^high^ pT~FH~ population, although we detected the most IL-21 in non-pT~FH~ cells, which were CCR7^low^ and CXCR5^low^. In addition to IL-21, the CCR7^high^CXCR5^high^CCR6^high^ pT~FH~ population produced IL-2 and IL-17, cytokines characteristic of T~H1~ and T~H17~ cells, respectively. However, from HIV-infected individuals we observed a loss of CCR7^high^CXCR5^high^CCR6^high^ cells making IL-2, IL-17 and IL-21.

No relationship between pT~FH~ cells and neutralization activity {#s2e}
----------------------------------------------------------------

Previous studies have described a relationship between the frequency of peripheral CXCR5^high^ cells and memory B cells and antibody titers with vaccination [@ppat.1003853-Pallikkuth1]. Therefore, we analyzed the relationship between the frequency of pT~FH~ cells and IgG-positive memory B cells in PBMC from HIV-infected individuals. We found no significant correlation between the frequency of pT~FH~ cells and IgG-positive B cells ([Figure 5A](#ppat-1003853-g005){ref-type="fig"}). Similarly, we failed to detect a relationship between the frequency of pT~FH~ and HIV-1 Env-specific antibody titers or total plasma IgG levels (data not shown).

![Relationship between pT~FH~ cells and neutralization activity.\
(**A**) Correlative analysis showing the frequency (%) of CXCR5^high^, CXCR5^high^CCR6^high^ and CXCR5^high^CCR6^high^PD-1^high^ populations in total CD4 cells from HIV-infected (treatment naïve) subjects (n = 50) versus the frequency of IgG+ B cells in the total B population. Correlations were analyzed using the nonparametric Spearman test. (**B**) Pooled data showing the frequency (%) of CXCR5^high^, CXCR5^high^CCR6^high^ and CXCR5^high^CCR6^high^PD-1^high^ populations in total CD4 cells based on neutralization activity (median ID50\>100 or \<100). No significant differences were determined.](ppat.1003853.g005){#ppat-1003853-g005}

It has also been reported that PD-1^high^ CD4 T cells in blood are associated with cross-clade neutralizing antibody responses during HIV infection [@ppat.1003853-Mikell1] and these PD-1^high^ CD4 T cells may represent a population of pT~FH~ cells. Thus, the relationship between pT~FH~ cells and neutralization activity was analyzed using HIV-infected samples classified as good neutralizers (median ID50\>100) or poor neutralizers (median ID50\<100) [@ppat.1003853-DoriaRose1]. Irrespective of how pT~FH~ cells were defined, we failed to find any relationship between neutralization activity and pT~FH~ cells ([Figure 5B](#ppat-1003853-g005){ref-type="fig"}).

Relationship between pT~FH~ cells and T~FH~ cells in human tonsil {#s2f}
-----------------------------------------------------------------

While pT~FH~ cells induce B cell differentiation and immunoglobulin secretion *in vitro*, the relationship between pT~FH~ and T~FH~ cells in secondary lymphoid organs remains unclear. Our *in vitro* coculture studies indicated the greatest isotype-switched immunoglobulin production was elicited from B cells cocultivated with CXCR5^high^CCR6^high^ pT~FH~ cells ([Figure 1B](#ppat-1003853-g001){ref-type="fig"}). Therefore, we investigated the expression of CCR6 on T~FH~ (CXCR5^high^PD-1^high^) and non-T~FH~ (CXCR5^low^PD-1^low^) tonsil cells to determine if the CXCR5^high^CCR6^high^ pT~FH~ population is related to T~FH~ cells within secondary lymphoid organs ([Figure 6A](#ppat-1003853-g006){ref-type="fig"}). The lowest frequency of CCR6^high^ cells was found within the CXCR5^high^PD-1^high^ compartment (1.5% of CXCR5^high^PD-1^high^ cells) and the greatest frequency of CCR6^high^ cells within the non-T~FH~ compartment (9% of CXCR5^low^PD-1^low^ cells; [Figure 6B](#ppat-1003853-g006){ref-type="fig"}).

![Relationship between pT~FH~ cells and T~FH~ cells in human tonsil.\
(**A**) Representative flow cytometry plots from HIV-uninfected, pediatric tonsils showing the gating scheme for determining the frequency of CCR6^high^ cells in T~FH~ (CXCR5^high^PD-1^high^) and non-T~FH~ populations. (**B**) Bar graphs showing the frequency of CCR6^high^ cells in T~FH~ and non-T~FH~ populations in human tonsils (n = 5). (**C**) Heatmap analysis of selected genes from RNA-seq data comparing pT~FH~ cells (CXCR5^high^CCR6^high^PD-1^high^) from HIV-uninfected donors, pT~FH~ cells from HIV-infected donors, non-T~FH~ CD4 memory tonsil cells (CM CD57^low^PD-1^dim^CCR7^high^CCR5^low^CXCR4^low^), non-germinal center T~FH~ tonsil cells (CM CD57^low^PD-1^high^CCR7^low^CXCR5^high^) and germinal center T~FH~ tonsil cells (CM PD-1^high^CD57^high^) from HIV-uninfected donors. (**D**) Top: Comparison of MAF expression on CD4 T cells from blood or tonsil. Bottom: Geometric mean (MFI) of MAF expression in the indicated populations of central memory CD4 T cells normalized to MAF MFI in naïve CD4 T cells.](ppat.1003853.g006){#ppat-1003853-g006}

Similarly, RNA sequence data from the CXCR5^high^CCR6^high^PD-1^high^ pT~FH~ population more closely resembles a memory, non-T~FH~ CD4 T cell population from the tonsil (CM CD57^low^PD-1^dim^CCR7^high^CCR5^low^CXCR4^low^) as compared to the non-germinal center T~FH~ population (CM CD57^low^PD-1^high^CCR7^low^CXCR5^high^) or the GC-T~FH~ population (CM PD-1^high^CD57^high^; [Figure 6C](#ppat-1003853-g006){ref-type="fig"}). In agreement with previous reports [@ppat.1003853-Kim1], [@ppat.1003853-Chevalier1], tonsil T~FH~ populations expressed higher levels of BCL6, IL-21, and CXCL13, and lower levels of PRDM1 and S1PR1 compared to the non-T~FH~ memory population. The pT~FH~ population from HIV-uninfected individuals expressed comparable levels of S1PR1 and PRDM1 to the non-T~FH~ memory population in the tonsil ([Figure 6](#ppat-1003853-g006){ref-type="fig"}). We also observed lower transcript levels of MAF, BCL6, IL-21, and CXCL-13 in the pT~FH~ population compared to tonsillar T~FH~ populations. Importantly, MAF protein expression was highest in the CCR6^high^PD-1^high^ pT~FH~ population compared to other peripheral populations, although still lower than tonsillar T~FH~ cells. ([Figure 6D](#ppat-1003853-g006){ref-type="fig"}). For many of the selected genes, pT~FH~ cells from HIV-infected subjects were comparable to pT~FH~ from HIV-uninfected individuals, however, we observed greater transcript levels of activation molecules such as ICOS and CD69. Additionally, the levels of IL-21 were decreased in pT~FH~ cells from HIV-infected individuals, supporting earlier results ([Figure 4B](#ppat-1003853-g004){ref-type="fig"}). Collectively, our data suggest the pT~FH~ population characterized as CXCR5^high^CCR6^high^ most closely resembles a non-T~FH~ memory population in the tonsil.

Discussion {#s3}
==========

The development and nature of human T~FH~ memory cells following an effector immune response are not known. The ability to define a population of memory T~FH~ cells in PBMC (pT~FH~) would help inform our understanding of CD4 T cell dynamics within lymphoid tissue during vaccination or infection. Studies of chronic infection may be helpful in this regard [@ppat.1003853-Hale1]. Whether the accumulation of T~FH~ cells during chronic infection [@ppat.1003853-Petrovas1], [@ppat.1003853-Lindqvist1] impacts the T~FH~ memory population is of particular interest, especially if memory T~FH~ cells migrate between lymphoid organs and peripheral tissues. Recent studies [@ppat.1003853-Morita1], [@ppat.1003853-Pallikkuth1] have suggested that circulating CXCR5^high^ CD4 T cells may represent the peripheral counterparts of T~FH~ cells. However, the relationship between pT~FH~ and T~FH~ cells within secondary lymphoid organs remains unclear. Therefore, it is of great relevance to determine if pT~FH~ cells originate from GC-T~FH~ cells and represent a memory T~FH~ population, reflect a precursor population that differentiates into GC-T~FH~ upon re-exposure to antigen, or both. Our studies begin to address these issues by further defining pT~FH~ cells, comparing pT~FH~ cells to tonsillar T~FH~ cells, and analyzing the effect of HIV on these cells.

In concordance with previous studies, we showed that circulating CXCR5^high^ CD4 T cells support B cell differentiation *in vitro* [@ppat.1003853-Morita1], [@ppat.1003853-Chevalier1]. A majority of the CXCR5^high^ cells expressed CD150, and while CD150 was used for gating in the co-culture assays, we found it did not impact the loss of pT~FH~ cells or effect our results with respect to loss of pT~FH~ cells, recovery with ART or lack of association with B cell or antibody responses (data not shown). However, within the CXCR5^high^ population the expression of CCR6 and PD-1 did further define pT~FH~ populations with differential abilities for naïve B cell help and isotype switching. Thus, pT~FH~ cell populations support both the activation and maturation of naïve B cells, and immunoglobulin isotype switching. Correspondingly, the individual pT~FH~ populations produced cytokines associated with B cell maturation and survival, such as IL-21 [@ppat.1003853-Linterman1], IL-2 [@ppat.1003853-LeGallou1] and IL-17 [@ppat.1003853-Doreau1], in contrast to T~FH~ cells within secondary lymphoid tissue, which display a limited cytokine profile that includes IL-4, IL-10 and IL-21, but compromised production of IL-2 and IL-17 [@ppat.1003853-Petrovas1]. Whether these pT~FH~ populations represent different stages of T~FH~ memory development or originate from separate CD4 T cell populations within lymphoid tissue [@ppat.1003853-Bentebibel1] is still unclear.

In order to better understand the relationship between T~FH~ and pT~FH~ cells, we compared gene expression levels between pT~FH~ and tonsillar CD4 T cell populations and focused on genes important for T~FH~ differentiation, migration, and function. We found that the pT~FH~ population with the greatest B cell helper function most closely resembled a CM, non-T~FH~ CD4 T cell subset within the tonsil. While our studies do not directly address the relationship between GC-T~FH~ in lymph nodes and circulating CD4 T cells from the same patients, our data challenge whether pT~FH~ are memory T~FH~ cells. A recent study reported that germinal center T~FH~ cells in mice migrate throughout the follicle, but generally do not leave the follicle to enter the blood [@ppat.1003853-Shulman1]. While it is conceivable that pT~FH~ cells represent a very minor population of T~FH~ cells that exit the follicle, it is also possible that pT~FH~ cells are reflective of a precursor T~FH~ population that exits the lymphoid organ and enters the circulation before entering the follicle. However, while we find the CXCR5^high^CCR6^high^PD-1^high^ pT~FH~ population does not resemble a memory T~FH~ population, Locci and colleagues found a CXCR5+CXCR3-PD-1+ pT~FH~ subset that functionally and transcriptionally resembles a memory T~FH~ population [@ppat.1003853-Locci1]. A recent study in mice reported that memory T~FH~ cells have reduced mRNA expression of T~FH~ markers such as Bcl6, IL-21, ICOS and PD-1 compared to the effector T~FH~ population [@ppat.1003853-Hale2], indicating the expression of these molecules may change depending on the phase of infection. Therefore, further investigation of pT~FH~ subsets and their relationship to memory and effector populations at multiple stages of infection is needed.

pT~FH~ and naïve B cell co-cultures from HIV-infected subjects produced fewer immunoglobulins compared to co-cultures from HIV-uninfected subjects. The observed defect in immunoglobulin production is likely due to impaired pT~FH~ help to B cells instead of B cell dysfunction, as co-cultures included naïve B cells rather than memory B cells that exhibit abnormalities in HIV infection [@ppat.1003853-Malaspina1]. Furthermore, while co-culture supernatants from HIV-infected subjects demonstrated a heterogeneous cytokine profile, similar to HIV-uninfected subjects, intracellular cytokine staining showed that fewer CCR7^high^CXCR5^high^CCR6^high^ pT~FH~ cells produced IL-2, IL-17 and IL-21 in chronic HIV infection compared to HIV-uninfected individuals. Furthermore, gene expression analysis of HIV-infected pT~FH~ revealed fewer IL-21 and IL-4 transcripts, although the overall levels of cytokine transcripts were low.

Recent studies have shown T~FH~ cells within secondary lymphoid organs accumulate in some donors or animals during chronic HIV/SIV infection and that T~FH~ accumulation is associated with GC B cell expansion and increased serum immunoglobulin concentrations [@ppat.1003853-Petrovas1], [@ppat.1003853-Linterman1], [@ppat.1003853-Harker1]. In contrast to T~FH~ cells, our studies revealed pT~FH~ cells consistently decrease in chronic HIV infection, with disease progression resulting in a greater reduction of these compartments within the total CD4 T cell population. However, it should be noted that we were unable to analyze T~FH~ cells within secondary lymphoid organs from these subjects and therefore we are unable to directly compare the frequency of pT~FH~ cells and T~FH~ cells from the same individual. The differences between the increase in T~FH~ cells and decrease in pT~FH~ cells may be due to differences in disease state (i.e. early vs late infection) or represent a steady state of T~FH~ cells trafficking between the lymphoid tissue and the blood. The decreased frequency of pT~FH~ in the blood may indicate impaired ability of T~FH~ to exit the lymph node in chronic HIV infection where the tissue architecture is not intact. Alternatively, the decreased frequency of pT~FH~ in the blood may be a result of pT~FH~ trafficking to secondary lymphoid organs. In agreement with previous studies [@ppat.1003853-Morita1], [@ppat.1003853-Chevalier1], we found a majority of CXCR5^high^ cells express CCR7, and it has previously been suggested that pT~FH~ cells migrate to secondary lymphoid organs upon infection due their expression of CCR7 and CD62L [@ppat.1003853-Morita1].

A confounding factor with regard to how we interpret the decrease in pT~FH~ cells is that we also found a reduction in the surface expression of CXCR5 on CD4 T cells in chronic HIV infection, which may result from increased sera levels of CXCL-13 [@ppat.1003853-Cagigi1], [@ppat.1003853-Widney1]. Furthermore, our co-culture data indicate that CXCR5^low^ CD4 T cells from viremic subjects can induce some B cell differentiation. These data support the possibility that in chronic HIV infection, a subset of functional pT~FH~ cells may be phenotypically defined as CXCR5^low^. Additionally, it should be noted that analysis of cellular subsets within the CXCR5^high^ population in chronic HIV infection revealed the frequency of CCR6^high^PD-1^high^ cells increased. These results are consistent with a state of generalized immune activation, as we also observed increased surface expression of ICOS on CXCR5^high^ and CXCR5^high^PD-1^high^ cells, and a positive association between the frequency of PD-1^high^ cells within the CXCR5^high^ population and serum concentrations of soluble CD14 [@ppat.1003853-Sandler1]. Similarly, gene expression analysis indicated increased transcript levels of activation markers, such as ICOS and CD69 within the pT~FH~ population during HIV infection. Overall, these data emphasize the difficulty in defining pT~FH~ cells in chronic HIV infection and understanding the relationship between pT~FH~ cells and T~FH~ cells.

The uncertain definition of pT~FH~ cells in HIV infection may provide an explanation as to why we were unable to identify correlations between pT~FH~ populations and circulating IgG-positive memory B cells, or between pT~FH~ cells and HIV-specific IgG (data not shown). Furthermore, we found no correlation between the frequency of pT~FH~ and the neutralization activity of a well-characterized cohort of HIV-infected donors [@ppat.1003853-DoriaRose1]. However, the absence of a correlation between pT~FH~ cells and circulating HIV Env-specific IgG may also be explained by the lack of a time-dependent association (early vs. late infection) between T~FH~ and pT~FH~ cells, or indicate that the generation of IgG and broadly neutralizing antibodies is regulated by parameters other than pT~FH~, confounded by T-cell independent antibody production commonly observed in HIV infection [@ppat.1003853-He1] or generalized immune activation. Thus, our data challenge the application of the pT~FH~ population as a surrogate of GC T~FH~-B cell interactions in chronic HIV infection. While our studies did not find a correlation between pT~FH~ cells and neutralizing antibodies, several recent studies, each with a different definition of pT~FH~ cells, have reported an association with antibody responses during vaccination, infection or autoimmune disease [@ppat.1003853-Locci1], [@ppat.1003853-Bentebibel2]--[@ppat.1003853-He2]. Therefore, further studies are needed to establish the association between pT~FH~ subsets and the generation of neutralizing antibodies, especially in HIV infection.

Overall, our data indicate that a range of circulating CD4 T cell populations can provide B cell help, possibly through differential secretion of soluble factors and/or cell-cell contact interactions [@ppat.1003853-Chevalier1], [@ppat.1003853-Bentebibel2] and that HIV infection results in loss of these cells over time, but with relative increases within the CXCR5^high^ compartment which may be explained by immune activation. Furthermore, we did not find any association between pT~FH~ and measures of B cell function such as HIV neutralization breadth/potency, HIV-specific IgG, or total IgG, suggesting application of this population as a surrogate of GC T~FH~-B cell interactions during HIV infection may be limited. A better understanding of the differentiation process and the developmental relationship between pT~FH~ subsets and lymph node T~FH~ cells is critical for the establishment of reliable peripheral blood CD4 T cell correlates for monitoring infection- or vaccine-associated B cell responses.

Materials and Methods {#s4}
=====================

Ethics statement {#s4a}
----------------

Signed informed consent was obtained in accordance with the Declaration of Helsinki and approved by the appropriate Institutional Review Board. Tonsil cells were acquired from anonymized discarded pathologic specimens from Children\'s National Medical Center (CNMC) under the auspices of the Basic Science Core of the District of Columbia Developmental Center for AIDS Research. The CNMC Institutional Review Board determined that study of anonymized discarded tonsils did not constitute 'human subjects research.'

Subjects {#s4b}
--------

Fresh HIV-uninfected peripheral blood mononuclear cells (PBMC) were obtained from individuals participating in the NIH research apheresis program. Fresh HIV-infected blood was obtained from the Vaccine Research Center Clinic or Drexel University College of Medicine. Frozen HIV-infected PBMC were obtained from three study populations ([Table S1](#ppat.1003853.s004){ref-type="supplementary-material"}). For untreated HIV infection, cells were obtained from volunteers who participated in a therapeutic vaccination trial (no efficacy was observed) conducted in the 1990\'s prior to the advent of combination antiretroviral therapy (cART) [@ppat.1003853-Birx1]. The second study population consisted of donors from a cohort used to identify individuals with HIV broadly neutralizing antibodies [@ppat.1003853-DoriaRose1]. To study the effect of cART, we obtained PBMC from HIV-infected donors participating in AIDS Clinical Trials Group study A5142 prior to initiation of cART and 24 and 48 weeks post-therapy [@ppat.1003853-Haubrich1], [@ppat.1003853-Riddler1]. PBMC and tonsil cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin and 100 µg/mL streptomycin (Invitrogen).

Antibodies {#s4c}
----------

Directly conjugated antibodies were acquired from the following: (1) BD Biosciences: CD3-H7APC, CXCR5-Alexa488 (RF8B2), CCR7-Alexa700, IgG-APC, IFN-γ-Alexa700 and IL-21-Alexa647 (3A3-N2.1) (2) Beckman Coulter: CD45RO-ECD and CD27-PC5 (3) Biolegend: CCR7-BV421, CCR6-PE (TG7/CCR6), CCR6-Alexa647 (TG7/CCR6), CD20-BV570, CD150-PE, IL-2-BV605, IL-17a-Cy5.5PerCP and CD154-Cy5PE (4) Invitrogen: CD4-Cy5.5PE, CD27-QD655, CD27-QD605 and CD19-PacBlue (5) Southern Biotech: IgD-FITC and IgD-PE (6) eBioscience: cmaf-eFluor660 (sym0F1), CXCR5-PerCP-efluor710 (MU5UBEE). Biotinylated anti-PD-1 was from R&D and streptavidin-Cy7PE (or QD655) was from Molecular Probes. The following antibodies were conjugated in our lab: CD19-QD705 and CD57-QD565. Quantum dots and Aqua amine viability dye were obtained from Invitrogen.

Polychromatic flow cytometry {#s4d}
----------------------------

### Phenotypic analysis {#s4d1}

1--2×10^6^ PBMC were incubated with Aqua-dye and surface stained with titrated amounts of anti-CD3, anti-CD4, anti-CD27, anti-CD45RO, anti-CCR7, anti-CXCR5, anti-CD150, anti-CCR6, anti-PD-1 and anti-CD19. Post-wash, cells were incubated with fluorescent-conjugated streptavidin, washed and fixed with 1% paraformaldehyde.

### Intracellular cytokine staining {#s4d2}

3×10^6^ PBMC were incubated in 1 mL of medium containing brefeldin A (10 ug/mL) in the absence or presence of HIV-1 Gag-peptide pools (15mers overlapping by 11 residues; NIH AIDS Research and Reference Reagent Program) or 1 ug/mL SEB (Sigma) for 6 hours. Cells were surface stained, permeabilized (Cytofix/Cytoperm kit; BD Biosciences), and stained with anti-CD3, anti-IFN-γ, anti-IL-2, anti-IL-17a, anti-IL-21 and anti-CD154. Events were collected on a modified LSRII flow cytometer (BD Immunocytometry Systems) and electronic compensation was performed with antibody capture beads (BD Biosciences). Data were analyzed using FlowJo Version 9.6 (TreeStar).

T and B cell culture {#s4e}
--------------------

Co-culture experiments were performed with freshly isolated PBMC. 5×10^4^ CD4 T cell populations were sorted based on expression of CCR7, CXCR5, CD150, CCR6 and PD-1 and cultured with 5×10^4^ autologous naïve B cells (1∶1 ratio) in the presence of SEB (0.5 µg/ml). Supernatants harvested on Day 2 were analyzed for cytokines using Luminex technology (Milliplex MAP Kit, HTH17MAG-14K, Millipore). The lower limit of detection (LOD) was set at the lowest concentration on the standard curve and values below the LOD were counted as zero. Supernatants collected on Day 12 were analyzed for immunoglobulins (Milliplex MAP Kit, HGAMMAG-301K). Some supernatants exceeded the saturation limit of the standard curves for IgM and IgG3. These values were included in the analysis and quantified as being equivalent to the highest determined concentration.

ELISA {#s4f}
-----

Soluble CD14 and CXCL-13 (R&D Systems) were measured in plasma or sera from HIV-infection patients according to the manufacturer\'s instructions.

CXCL-13 treatment {#s4g}
-----------------

Freshly isolated PBMCs were incubated with recombinant human CXCL-13 (R&D Systems) at 37°C or 4°C and analyzed for CXCR5 surface expression by FACS.

Illumina deep sequencing of messenger RNA {#s4h}
-----------------------------------------

CD4 T cell populations were sorted from uninfected PBMC (n = 5), HIV-infected PBMC (n = 5) and uninfected human tonsils (n = 4) based on expression of CCR7, CXCR5, CD150, CCR6 and PD-1 for PBMC and CD57, PD-1, CCR7, CXCR5, CCR5 and CXCR4 for tonsils. Total RNA was purified from sorted cell populations and treated with DNAse I (Ambion) to minimize genomic DNA contamination. Polyadenylated RNA was isolated using Oligo-dT Dynabeads (Life Technologies), chemically fragmented, and used to construct barcoded Illumina Truseq libraries. Libraries were size-selected, quantified, pooled, size-selected and quantified again, and clustered on an Illumina Truseq Paired-End Flowcell v3. The flowcell was sequenced on an Illumina HiSeq 2000 in a 2×75-base paired-end, indexed run. Adaptor sequence was trimmed from the raw sequencing reads using Trimmomatic. The trimmed sequencing reads were subsequently aligned to the human genome (hg19) using TopHat 2. Differential expression testing was done using Cufflinks 2 and visualization of differential expression was done using the R package cummerbund. Accession numbers of the selected genes are shown in Supporting [Table S2](#ppat.1003853.s005){ref-type="supplementary-material"}.

Virus neutralization {#s4i}
--------------------

Neutralization activity of patient sera was determined against 20 viral isolates using a TZM-bl neutralization assay as previously described [@ppat.1003853-DoriaRose1].

In vitro infection {#s4j}
------------------

Freshly isolated PBMCs were stimulated with PHA (10 µg/ml). After 12 hours stimulation, CXCR5^high^ cells were sorted by FACS Aria based on surface molecule expression and infected by a multiplicity of infection (MOI) of 0.01 with either HIV NL-E or HIV NLAD8-E [@ppat.1003853-Cooper1]. The infected cells were cultured in the presence of 50 U/ml recombinant human interleukin-2 (R&D) for 5 days and analyzed for CXCR5 expression by FACS.

Statistics {#s4k}
----------

Experimental variables were analyzed using the nonparametric Mann-Whitney U test, the Wilcoxon matched-pairs signed rank test or the Friedman test with Dunn\'s multiple comparison post-test. Correlation analysis was performed using the nonparametric Spearman test. Error bars depict mean+SEM in all bar graphs shown. The GraphPad Prism statistical analysis program (GraphPad Software, version 5.0) was used throughout.

Supporting Information {#s5}
======================

###### 

**Characterization of peripheral T~FH~ cells.** (**A**) Scatter plot depicting frequency of IgG+ and IgA+ B cells in total B (CD19+) or naïve B cells (CD19^+^CD27^low^IgD^high^) for HIV-uninfected (n = 5), HIV-infected (non-viremic; n = 7) and HIV-infected (viremic; n = 1) donors. Both surface and intracellular staining of IgA and IgG were used to determine frequency. (**B**) Left: Representative flow cytometry plots from HIV-uninfected PBMC showing CXCR3 and CCR6 expression within CXCR5^high^ and CXCR5^low^ CD4 T cell subsets. Right: Scatter plot comparing the frequency of CXCR3 and CCR6 subsets within the CXCR5^high^ population from HIV-uninfected (open circles; n = 4) and HIV-infected individuals (closed circles; n = 8).

(EPS)

###### 

Click here for additional data file.

###### 

**Decrease of pT~FH~ cells in HIV infection.** (**A**) Pooled data showing the frequency (%) of indicated populations in CXCR5-expressing cells from PBMC from HIV-uninfected (open circles; n = 13), HIV-infected (treatment-naïve), CD4 count \>200 (light gray circles; *n* = 44), and HIV-infected (treatment-naïve), CD4 count \<200 (black circles; *n* = 22). Significant differences between uninfected and HIV-infected subjects were determined using the Mann-Whitney U test. \*\*\*p\<0.001; \*\*p\<0.01; \*p\<0.05. Far Right: Correlative analysis between the frequency of CXCR5^high^PD-1^high^ cells and the concentration of soluble CD14 in the sera or plasma. The trend did not reach statistical significance as determined by the Spearman test. (**B**) Top: Longitudinal analysis showing the frequency (%) of indicated populations in CXCR5-expressing cells from HIV-infected (treatment naïve) subjects (n = 10) over 36--48 months. No significant correlations were found. Bottom: Longitudinal analysis showing CD4 counts and viral loads from HIV-infected (treatment naïve) subjects (n = 10) over 36--48 months. (**C**) Pooled data showing the frequency (%) of indicated populations in CXCR5-expressing cells from PBMC from HIV-uninfected subjects (open circles; n = 13) and HIV-infected subjects before (n = 14, week 0; black circles) and after ART (week 24, dark gray circles; week 48, light gray circles).

(EPS)

###### 

Click here for additional data file.

###### 

**Characterization of pT~FH~ cells in HIV infection.** (**A**) CCR7^high^CXCR5^low^ and CCR7^high^CXCR5^high^CCR6^high^ CD4 T cells isolated from PBMCs were cultured with autologous naïve B cells (CD19^high^CD27^low^IgD^−^) in the presence of SEB for 2 days and cytokine concentrations were measured from supernatants (HIV-uninfected, n = 5; HIV-infected (non-viremic), n = 4, HIV-infected (viremic), n = 0--1). Due to limited cell numbers we were unable to collect CCR7^high^CXCR5^high^CCR6^high^ cells from viremic individuals. (**B**) Sorted CXCR5^high^ central memory cells isolated from blood do not down-regulate surface expression of CXCR5 upon X4 or R5 *in vitro* infection.

(EPS)

###### 

Click here for additional data file.

###### 

**CD4 count, viral load and neutralization activity of subjects studied.**

(EPS)

###### 

Click here for additional data file.

###### 

**Accession numbers of selected genes.**

(EPS)

###### 

Click here for additional data file.
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